ATE71657T1 - Protein-a material und dessen herstellung. - Google Patents

Protein-a material und dessen herstellung.

Info

Publication number
ATE71657T1
ATE71657T1 AT83306500T AT83306500T ATE71657T1 AT E71657 T1 ATE71657 T1 AT E71657T1 AT 83306500 T AT83306500 T AT 83306500T AT 83306500 T AT83306500 T AT 83306500T AT E71657 T1 ATE71657 T1 AT E71657T1
Authority
AT
Austria
Prior art keywords
protein
cloning
nucleotide sequence
manufacture
gene
Prior art date
Application number
AT83306500T
Other languages
English (en)
Inventor
Donald A Colbert
Algis Anilionis
Original Assignee
Repligen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repligen Corp filed Critical Repligen Corp
Application granted granted Critical
Publication of ATE71657T1 publication Critical patent/ATE71657T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT83306500T 1982-10-27 1983-10-26 Protein-a material und dessen herstellung. ATE71657T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/436,955 US5151350A (en) 1982-10-27 1982-10-27 Cloned genes encoding recombinant protein a
EP83306500A EP0107509B1 (de) 1982-10-27 1983-10-26 Protein-A Material und dessen Herstellung

Publications (1)

Publication Number Publication Date
ATE71657T1 true ATE71657T1 (de) 1992-02-15

Family

ID=23734479

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83306500T ATE71657T1 (de) 1982-10-27 1983-10-26 Protein-a material und dessen herstellung.

Country Status (6)

Country Link
US (1) US5151350A (de)
EP (1) EP0107509B1 (de)
JP (2) JPH0811068B2 (de)
AT (1) ATE71657T1 (de)
CA (1) CA1307483C (de)
DE (1) DE3382495D1 (de)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737544A (en) * 1982-08-12 1988-04-12 Biospecific Technologies, Inc. Biospecific polymers
US4691009A (en) * 1984-12-26 1987-09-01 Repligen Corporation Hybrid proteins produced by an ultrahigh prokaryotic expression system
SE459503B (sv) * 1985-05-03 1989-07-10 Excorim Kommanditbolag Hybrid-dna-molekyl innefattande dna-sekvens som kodar foer protein g samt foerfarande foer framstaellning av protein g
DK528285D0 (da) * 1985-11-15 1985-11-15 Novo Industri As Peptider samt praeparater indeholdende disse
EP0234592A1 (de) * 1986-02-28 1987-09-02 Teijin Limited Plasmid, das ein DNA-Fragment enthält, welches für die Fc-Region von menschlichem Immunoglobulin G Protein codiert, und Verwendung desselben zur Herstellung des genannten Proteins
SE459662B (sv) * 1986-03-21 1989-07-24 Pharmacia Ab Hybrid-dna-molekyl som kodar foer ett protein med samma igg specificitet som protein g, plasmid innehaallande densamma samt foerfarande foer framstaellning av proteinet
US4876194A (en) * 1986-07-22 1989-10-24 Hightech Receptor Ab Protein L and subfragments thereof, with immunoglobulin binding activity, a process for preparing thereof, reagent kit, pharmaceutical composition and a peptococcus magnus strain
JPS6348297A (ja) * 1986-08-18 1988-02-29 Sanraku Inc Ｆｃ結合性蛋白質及びその生産菌
EP0289129A3 (de) * 1987-03-26 1990-10-10 Repligen Corporation Herstellung von hochgereinigtem Protein A
US5084559A (en) * 1987-03-27 1992-01-28 Repligen Corporation Protein a domain mutants
AU623361B2 (en) * 1987-11-20 1992-05-14 Creative Biomolecules, Inc. Selective removal of immune complexes
US5084398A (en) * 1987-11-20 1992-01-28 Creative Biomolecules Selective removal of immune complexes
US5243040A (en) * 1987-11-20 1993-09-07 Creative Biomolecules DNA encoding a protein which enables selective removal of immune complexes
ATE91152T1 (de) * 1988-07-22 1993-07-15 Imre Corp Gereinigte protein a-zusammensetzungen und verfahren zu ihrer herstellung.
JP2871709B2 (ja) * 1988-11-21 1999-03-17 住友製薬株式会社 免疫グロブリンｇ結合活性を有する新規な蛋白質プロテインｈ、該蛋白質をコードする遺伝子及び該蛋白質の製造法
JPH02308791A (ja) * 1989-05-24 1990-12-21 Sekisui Chem Co Ltd 免疫グロブリンＦｃ領域に対する結合能力とルシフェラーゼ活性をもつポリペプチド
GB9013872D0 (en) * 1990-06-21 1990-08-15 Inst Tecnologico Y Cientifico Use of protein a and polypeptide components thereof in the treatment of tumours
WO1992009633A1 (en) * 1990-11-26 1992-06-11 Public Health Laboratory Service Board Immunoglobulin-binding proteins and recombinant dna molecules coding therefor
JP2584697B2 (ja) * 1991-08-23 1997-02-26 オリエンタル酵母工業株式会社 ＩｇＧ精製用組換え型プロテインＡ
JP2519136B2 (ja) * 1991-07-25 1996-07-31 オリエンタル酵母工業株式会社 分子量マ−カ−
EP0863210A3 (de) * 1991-07-25 1999-09-22 Oriental Yeast Co., Ltd. Künstliches Immunglobulinkombinierendes Protein
GB9526359D0 (en) * 1995-12-22 1996-02-21 Smithkline Beecham Plc Novel compounds
GB9526356D0 (en) * 1995-12-22 1996-02-21 Smithkline Beecham Plc Novel compounds
US6001600A (en) * 1996-12-20 1999-12-14 Smithkline Beecham Plc DNA encoding tests polypeptides
GB9600955D0 (en) * 1996-01-17 1996-03-20 Smithkline Beecham Plc Novel compounds
WO2001009164A2 (en) * 1999-07-29 2001-02-08 The Rockefeller University Dna replication proteins of gram positive bacteria and their use to screen for chemical inhibitors
US7432365B1 (en) 1998-01-27 2008-10-07 O'donnell Michael E DNA molecules encoding beta clamp proteins of gram positive bacteria
AU2341699A (en) * 1998-01-27 1999-08-09 Rockefeller University, The Dna replication proteins of gram positive bacteria and their use to screen for chemical inhibitors
US20030167524A1 (en) * 2000-12-19 2003-09-04 Rooijen Gijs Van Methods for the production of multimeric protein complexes, and related compositions
EP1346056A1 (de) * 2000-12-19 2003-09-24 SemBioSys Genetics Inc. Methode zur herstellung von multimeren proteinen, und dazugehörende zusammensetzungen
US7098383B2 (en) * 2000-12-19 2006-08-29 Sembiosys Genetics Inc. Methods for the production of multimeric immunoglobulins, and related compositions
US20090137416A1 (en) 2001-01-16 2009-05-28 Regeneron Pharmaceuticals, Inc. Isolating Cells Expressing Secreted Proteins
US20060179514A1 (en) * 2001-07-05 2006-08-10 Sembiosys Genetics, Inc. Methods for the production of multimeric protein complexes, and related compositions
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
JP2005112827A (ja) * 2003-10-10 2005-04-28 National Institute Of Advanced Industrial & Technology 抗体アフィニティ担体
NZ548126A (en) * 2004-02-27 2009-10-30 Ge Healthcare Bio Sciences Ab A process for the purification of antibodies involving addition of a second resin
SE0400501D0 (sv) * 2004-02-27 2004-02-27 Amersham Biosciences Ab Antibody purification
CA2570253A1 (en) 2004-07-06 2006-01-12 Kaneka Corporation Process for producing protein a-like protein with use of brevibacillus genus bacaterium
WO2006014899A2 (en) 2004-07-26 2006-02-09 Dow Global Technologies Inc. Process for improved protein expression by strain engineering
AU2005296352B2 (en) 2004-10-21 2011-01-06 Cytiva Bioprocess R&D Ab Chromatography ligand
US8728828B2 (en) 2004-12-22 2014-05-20 Ge Healthcare Bio-Sciences Ab Purification of immunoglobulins
EP1746103A1 (de) 2005-07-20 2007-01-24 Applied NanoSystems B.V. Bifunktionelle Protein-Anker
US7375188B2 (en) * 2005-07-29 2008-05-20 Mallinckrodt Baker, Inc. Vegetarian protein a preparation and methods thereof
EP2066419B1 (de) 2006-09-29 2015-11-11 GE Healthcare Bio-Sciences AB Chromatographieligand mit domäne c von staphylococcus-aureus-protein a für die antikörperisolierung
WO2008127457A2 (en) * 2006-12-06 2008-10-23 Repligen Corporation Nucleic acids encoding recombinant protein a
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
KR101530395B1 (ko) 2007-04-27 2015-06-19 피페넥스 인크. 향상된 수율 및(또는) 품질로 이종 단백질을 발현하는 특정 균주를 동정하기 위해 미생물 숙주를 신속히 스크리닝하는 방법
EP2165758A4 (de) 2007-05-30 2016-08-03 Kaneka Corp Poröser träger mit formylgruppe, absorptionsmittel unter verwendung des porösen trägers, verfahren zur herstellung des porösen trägers und verfahren zur herstellung des absorptionsmittels
SG149759A1 (en) 2007-07-10 2009-02-27 Millipore Corp Media for affinity chromatography
US8592555B2 (en) 2008-08-11 2013-11-26 Emd Millipore Corporation Immunoglobulin-binding proteins with improved specificity
EP2335076B1 (de) * 2008-09-15 2012-08-08 EMD Millipore Corporation Verfahren zur quantifizierung des proteinverlusts von affinitätschromatographieharzen auf proteinbasis
JP5626526B2 (ja) 2008-09-25 2014-11-19 Jsr株式会社 アフィニティークロマトグラフィー用充填剤
CN103816870B (zh) 2008-12-03 2016-11-23 株式会社钟化 含有甲酰基的多孔性载体、使用该多孔性载体的吸附体以及它们的制造方法
SG195555A1 (en) 2008-12-24 2013-12-30 Emd Millipore Corp Caustic stable chromatography ligands
HRP20160274T1 (hr) 2009-04-03 2016-04-08 University Of Chicago Pripravci i metode vezane za varijante proteina a (spa)
WO2011125673A1 (ja) 2010-03-31 2011-10-13 Jsr株式会社 アフィニティークロマトグラフィー用充填剤
EP2588120B1 (de) 2010-07-02 2017-11-15 The University of Chicago Zusammensetzungen und verfahren bezüglich protein-a (spa)-varianten
WO2012124145A1 (ja) 2011-03-15 2012-09-20 オムロン株式会社 演算ユニット、支援装置、支援プログラム、支援プログラムを格納した記憶媒体、および、支援装置における動作方法
SG10201604559TA (en) 2011-06-08 2016-07-28 Emd Millipore Corp Chromatography matrices including novel staphylococcus aureus protein a based ligands
WO2014038686A1 (ja) 2012-09-10 2014-03-13 株式会社カネカ 吸着体
BR112015005937A2 (pt) 2012-09-17 2017-07-04 Grace W R & Co meios e dispositivos cromatográficos
TWI745610B (zh) 2012-11-14 2021-11-11 美商再生元醫藥公司 重組細胞表面捕捉蛋白質
US20160236171A1 (en) 2013-10-15 2016-08-18 Kaneka Corporation Method for producing porous cellulose beads
EP3059320A4 (de) 2013-10-15 2017-06-21 Kaneka Corporation Herstellungsverfahren für poröse celluloseperlen und absorptionsmittel damit
WO2015056681A1 (ja) 2013-10-15 2015-04-23 株式会社カネカ 多孔質セルロースビーズの製造方法およびそれを用いた吸着体
US11229896B2 (en) 2014-01-16 2022-01-25 W.R. Grace & Co.—Conn. Affinity chromatography media and chromatography devices
US20240100450A9 (en) * 2014-01-17 2024-03-28 Repligen Corporation Sterilizing chromatography columns
EP3094391B1 (de) * 2014-01-17 2024-11-20 Repligen Corporation Sterilisation von chromatografiesäulen
US11389783B2 (en) 2014-05-02 2022-07-19 W.R. Grace & Co.-Conn. Functionalized support material and methods of making and using functionalized support material
PL3302784T3 (pl) 2015-06-05 2022-01-17 W.R. Grace & Co.-Conn. Adsorbentowe środki klarujące do bioprzetwarzania oraz sposoby ich wytwarzania i stosowania
TWI888342B (zh) 2017-09-25 2025-07-01 日商Ｊｓｒ股份有限公司 免疫球蛋白結合蛋白質，及使用其之親和性載體
JP7159151B2 (ja) 2017-09-25 2022-10-24 Jsr株式会社 イムノグロブリン結合タンパク質、及びそれを用いたアフィニティー担体
JP7298607B2 (ja) 2018-06-20 2023-06-27 Jsr株式会社 変異ｖｈｈ抗体を用いたアフィニティー担体
EP3842536A4 (de) 2018-08-24 2023-01-18 JSR Corporation Immunglobulin-bindendes protein und affinitätsträger damit
CA3139981A1 (en) 2019-05-14 2020-11-19 The University Of Chicago Methods and compositions comprising staphylococcus protein a (spa) variants

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293652A (en) * 1979-05-25 1981-10-06 Cetus Corporation Method for synthesizing DNA sequentially
US4338397A (en) * 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
US4322274A (en) * 1980-08-28 1982-03-30 Wilson Gregory B Method of diagnosing cystic fibrosis patients and asymptomatic carrier of the cystic fibrosis gene
SE462046C (sv) * 1982-08-23 1998-04-27 Pharmacia Biotech Ab Hybrid-DNA-vektor innehållande DNA-sekvens från Staphylococcus aureus, förfarande för dess framställning och bakterie innehållande densamma
SE8204811L (sv) * 1982-08-23 1984-02-24 Sven Lofdahl Dna-fragment innefattande en signalsekvens
DE3314812A1 (de) * 1983-04-23 1984-10-25 Battelle-Institut E.V., 6000 Frankfurt Mittel zum antigen/antikoerper-nachweis
US4617266A (en) * 1983-04-28 1986-10-14 Genex Corporation Production of Protein A

Also Published As

Publication number Publication date
CA1307483C (en) 1992-09-15
JPH0811068B2 (ja) 1996-02-07
EP0107509A2 (de) 1984-05-02
JPH08107795A (ja) 1996-04-30
EP0107509B1 (de) 1992-01-15
US5151350A (en) 1992-09-29
DE3382495D1 (de) 1992-02-27
EP0107509A3 (en) 1986-03-26
JPS59113890A (ja) 1984-06-30

Similar Documents

Publication Publication Date Title
ATE71657T1 (de) Protein-a material und dessen herstellung.
Quaranta et al. Serologic and immunochemical characterization of the specificity of four monoclonal antibodies to distinct antigenic determinants expressed on subpopulations of human Ia-like antigens.
Murphy et al. SP-40, 40 is an inhibitor of C5b-6-initiated haemolysis
DK0492448T3 (da) Monoklonale antistoffer mod human tumor-nekrotiserende faktor alfa
Sheehan et al. Generation and characterization of monoclonal antibodies specific for the human IFN-gamma receptor.
DE3588219D1 (de) T-Zellenrezeptor, spezifisch für Antigenpolypeptide und verwandte Polynukleotide
Hecht et al. Production and characterization of a monoclonal antibody that binds Reed-Sternberg cells.
ATE504601T1 (de) Anti-cd3-antikörper zur verwendung zur induzierung von immunsuppression
MY108519A (en) Novel antibodies reactive with human carcinomas.
ES8607564A1 (es) Un metodo para determinar la presencia de un determinante antigenico de interleuquina-2-en una muestra.
DK50497A (da) Monoklonale antistoffer over for nye faktor VIII-koaguleringspolypeptider
DE68925226D1 (de) Monoklonale Antikörper
DE69029808D1 (de) Monoklonale antikörper
DE3581288D1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
ZA917669B (en) Antagonists of human gamma interferon
ES8607024A1 (es) Anticuerpos monoclonales
KR900701318A (ko) 항-사람 고분자량- 흑색종 관련 항원에 대한 항-이디오 타입 항체
ATE151882T1 (de) Karzinomverwandtes haptoglobin (hpr)
ATE230418T1 (de) Monoklonaler antikörper gegen das humane mx- protein mxa
Natori et al. A mouse plasma substance carrying β2‐microglobulin activity and lacking in H‐2 alloantigenic activity
ATE94880T1 (de) Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung.
DK0542897T3 (da) Fremstilling af monoklonale antistoffer mod humant Vbeta-T-cellereceptorelement ved anvendelse af rekombinante DNA-vektorer
Kokai et al. Characterization of two distinct antigens expressed on either resting or activated human B cells as defined by monoclonal antibodies
Yang et al. Distribution of haptoglobin phenotypes in a Korean population, using the semi-automated PhastSystem
SE8201226L (sv) Antikroppar mot proteiner

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time